GF Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Buy
10,234
+108
+1% +$51.8K 0.06% 131
2026
Q1
$4.98M Hold
10,126
0.08% 132
2025
Q4
$5.87M Sell
10,126
-191
-2% -$108K 0.1% 139
2025
Q3
$5M Buy
10,317
+911
+10% +$424K 0.09% 142
2025
Q2
$3.81M Sell
9,406
-70
-0.7% -$29.3K 0.08% 158
2025
Q1
$4.72M Hold
9,476
0.11% 142
2024
Q4
$4.93M Buy
+9,476
New +$5.21M 0.11% 143

Other funds holding TMO

GF Fund Management's TMO Position: Q2 2026 in Review

GF Fund Management increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $51.8K and bringing the position to 10,234 shares worth $5.13M. The position accounts for 0.06% of the portfolio, ranked #131.

GF Fund Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.87M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • GF Fund Management held 10,234 shares of Thermo Fisher Scientific worth $5.13M as of Q2 2026.
  • GF Fund Management bought 108 Thermo Fisher Scientific shares in Q2 2026, an estimated $51.8K.
  • Thermo Fisher Scientific made up 0.06% of GF Fund Management's portfolio in Q2 2026, its #131 holding.
  • GF Fund Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Thermo Fisher Scientific position peaked at $5.87M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.